Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Allovir Inc stock
Learn how to easily invest in Allovir Inc stock.
Allovir Inc is a biotechnology business based in the US. Allovir Inc shares (ALVR) are listed on the NASDAQ and all prices are listed in US Dollars. Allovir Inc employs 107 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Allovir Inc
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ALVR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Allovir Inc stock price (NASDAQ: ALVR)Use our graph to track the performance of ALVR stocks over time.
Allovir Inc shares at a glance
|Latest market close||$7.85|
|52-week range||$3.17 - $26.41|
|50-day moving average||$7.01|
|200-day moving average||$7.34|
|Wall St. target price||$26.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.92|
Buy Allovir Inc shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Allovir Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Allovir Inc price performance over time
|1 week (2022-09-23)||6.22%|
|1 month (2022-09-01)||4.67%|
|3 months (2022-07-01)||90.07%|
|6 months (2022-04-01)||13.77%|
|1 year (2021-10-01)||-69.80%|
|2 years (2020-10-01)||-71.93%|
|3 years (2019-09-27)||N/A|
|5 years (2017-09-27)||N/A|
Allovir Inc financials
|Gross profit TTM||$165,000|
|Return on assets TTM||-44.81%|
|Return on equity TTM||-83.35%|
|Market capitalisation||$687.7 million|
TTM: trailing 12 months
Allovir Inc share dividends
We're not expecting Allovir Inc to pay a dividend over the next 12 months.
Allovir Inc share price volatility
Over the last 12 months, Allovir Inc's shares have ranged in value from as little as $3.17 up to $26.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Allovir Inc's is 1.0016. This would suggest that Allovir Inc's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Allovir Inc overview
Allovir, Inc. , a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019.
Allovir Inc in the news
Wall Street Analysts See a 259% Upside in AlloVir, Inc. (ALVR): Can the Stock Really Move This High?
Frequently asked questionsWhat percentage of Allovir Inc is owned by insiders or institutions?
Currently 50.012% of Allovir Inc shares are held by insiders and 34.026% by institutions. How many people work for Allovir Inc?
Latest data suggests 107 work at Allovir Inc. When does the fiscal year end for Allovir Inc?
Allovir Inc's fiscal year ends in December. Where is Allovir Inc based?
Allovir Inc's address is: 1100 Winter Street, Waltham, MA, United States, 02451 What is Allovir Inc's ISIN number?
Allovir Inc's international securities identification number is: US0198181036
More guides on Finder
What are the best dividend stocks for 2022?
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Ask an Expert